AAM
CC icon

Aberdeen Asset Management’s Chemours CC Stock Holding History

Aberdeen Asset Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,558
Closed -$86K – 725
2015
Q4 		$86K Buy
13,558
+1,977
+17% +$12.6K ﹤0.01% 723
2015
Q3 		$75K Buy
+11,581
New +$121K ﹤0.01% 685

Other funds holding CC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CCM
Conatus Capital Management Greenwich, Connecticut $92.3M AUM 45.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Aberdeen Asset Management's CC Position: Q1 2016 in Review

Aberdeen Asset Management sold out of Chemours (CC) in Q1 2016, closing a stake of 13,558 shares — an estimated $86K sold.

Aberdeen Asset Management first reported a position in CC in Q3 2015 and held it in 2 quarters. The position peaked at $86K in Q4 2015. 416 funds tracked by Wall St. Rank hold CC as of Q1 2016.

  • Aberdeen Asset Management reported no remaining Chemours position as of Q1 2016 after selling out during the quarter.
  • Aberdeen Asset Management sold 13,558 Chemours shares in Q1 2016, an estimated $86K.
  • Aberdeen Asset Management first reported a position in Chemours in Q3 2015 and held it in 2 quarters.
  • Aberdeen Asset Management's Chemours position peaked at $86K in Q4 2015.
  • 416 funds tracked by Wall St. Rank held Chemours as of Q1 2016.

Based on Aberdeen Asset Management's 13F filing for Q1 2016, filed 16 May 2016.